Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

56 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Relationship between circulating FSH levels and body composition and bone health in patients with prostate cancer who undergo androgen deprivation therapy: The BLADE study.
Bergamini M, Dalla Volta A, Palumbo C, Zamboni S, Triggiani L, Zamparini M, Laganà M, Rinaudo L, Di Meo N, Caramella I, Bresciani R, Valcamonico F, Borghetti P, Guerini A, Farina D, Antonelli A, Simeone C, Mazziotti G, Berruti A. Bergamini M, et al. Among authors: guerini a. Elife. 2024 Apr 24;13:e92655. doi: 10.7554/eLife.92655. Elife. 2024. PMID: 38656229 Free PMC article. Clinical Trial.
Changes in body composition and lipid profile in prostate cancer patients without bone metastases given Degarelix treatment: the BLADE prospective cohort study.
Palumbo C, Antonelli A, Triggiani L, Dalla Volta A, Maffezzoni F, Zamboni S, Borghetti P, Rinaudo L, Valcamonico F, Maroldi R, Magrini SM, Simeone C, Berruti A; Collaborators. Palumbo C, et al. Prostate Cancer Prostatic Dis. 2021 Sep;24(3):852-859. doi: 10.1038/s41391-021-00345-0. Epub 2021 Mar 15. Prostate Cancer Prostatic Dis. 2021. PMID: 33723362 Free PMC article. Clinical Trial.
Heterogeneity in regional changes in body composition induced by androgen deprivation therapy in prostate cancer patients: potential impact on bone health-the BLADE study.
Dalla Volta A, Palumbo C, Zamboni S, Mazziotti G, Triggiani L, Zamparini M, Maffezzoni F, Rinaudo L, Bergamini M, Di Meo N, Caramella I, Valcamonico F, Borghetti P, Guerini A, Farina D, Antonelli A, Simeone C, Berruti A. Dalla Volta A, et al. Among authors: guerini a. J Endocrinol Invest. 2024 Feb;47(2):335-343. doi: 10.1007/s40618-023-02150-z. Epub 2023 Jul 17. J Endocrinol Invest. 2024. PMID: 37458931 Free PMC article.
Differential Diagnosis and Clinical Management of a Case of COVID-19 in a Patient With Stage III Lung Cancer Treated With Radio-chemotherapy and Durvalumab.
Guerini AE, Borghetti P, Filippi AR, Bonù ML, Tomasini D, Greco D, Imbrescia J, Volpi G, Triggiani L, Borghesi A, Maroldi R, Pasinetti N, Buglione M, Magrini SM. Guerini AE, et al. Clin Lung Cancer. 2020 Nov;21(6):e547-e550. doi: 10.1016/j.cllc.2020.05.027. Epub 2020 Jun 2. Clin Lung Cancer. 2020. PMID: 32527714 Free PMC article. No abstract available.
Stereotactic prostate radiotherapy with or without androgen deprivation therapy, study protocol for a phase III, multi-institutional randomized-controlled trial.
Bonù ML, Magli A, Tomasini D, Frassine F, Albano D, Arcangeli S, Bruni A, Ciccarelli S, De Angeli M, Francolini G, Franzese C, Ghirardelli P, Grazioli L, Guerini A, Lancia A, Marvaso G, Sepulcri M, Trodella LE, Morelli V, Georgopulos A, Domina AO, Granello L, Mataj E, Barbera F, Triggiani L. Bonù ML, et al. Among authors: guerini a. BJR Open. 2022 Nov 29;4(1):20220032. doi: 10.1259/bjro.20220032. eCollection 2022. BJR Open. 2022. PMID: 38525170 Free PMC article.
56 results